Sera Prognostics SERA Cost Of Revenue Excluding Selling Marketing General And Administrative Expense
Cost Of Revenue Excluding Selling Marketing General And Administrative Expense at other companies
Other financials
Where this comes from
Reported directly by Sera Prognostics in its filing.
Tagged under the XBRL concept sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense.
The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sera Prognostics's cost of revenue excluding selling marketing general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sera Prognostics's cost of revenue excluding selling marketing general and administrative expense?
- Sera Prognostics (SERA) reported cost of revenue excluding selling marketing general and administrative expense of $42K in Q1 2026.
- How has Sera Prognostics's cost of revenue excluding selling marketing general and administrative expense changed year-over-year?
- Sera Prognostics's cost of revenue excluding selling marketing general and administrative expense increased by 5.0% year-over-year, from $40K to $42K.
- What is the long-term trend for Sera Prognostics's cost of revenue excluding selling marketing general and administrative expense?
- Over 2 years (2023 to 2025), Sera Prognostics's cost of revenue excluding selling marketing general and administrative expense has grown at a -11.6% compound annual growth rate (CAGR), from $210K to $164K.
- What does cost of revenue excluding selling marketing general and administrative expense mean?
- This metric represents the direct costs associated with producing the goods or delivering the services sold by the company during the reporting period. It excludes indirect costs such as selling, marketing, and general administrative expenses to isolate the core cost of production. Monitoring this figure helps assess the direct efficiency and scalability of the company's diagnostic testing platform.